ZA200705106B - Nicotinic acetycholine receptor ligands - Google Patents
Nicotinic acetycholine receptor ligandsInfo
- Publication number
- ZA200705106B ZA200705106B ZA200705106A ZA200705106A ZA200705106B ZA 200705106 B ZA200705106 B ZA 200705106B ZA 200705106 A ZA200705106 A ZA 200705106A ZA 200705106 A ZA200705106 A ZA 200705106A ZA 200705106 B ZA200705106 B ZA 200705106B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor ligands
- nicotinic acetycholine
- acetycholine receptor
- nicotinic
- ligands
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63668004P | 2004-12-16 | 2004-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200705106B true ZA200705106B (en) | 2008-12-31 |
Family
ID=36588167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200705106A ZA200705106B (en) | 2004-12-16 | 2007-06-15 | Nicotinic acetycholine receptor ligands |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080103170A1 (xx) |
| EP (1) | EP1831212A4 (xx) |
| JP (1) | JP2008524212A (xx) |
| KR (1) | KR20070086273A (xx) |
| CN (1) | CN101119994A (xx) |
| AU (1) | AU2005317235A1 (xx) |
| BR (1) | BRPI0518547A2 (xx) |
| CA (1) | CA2592321A1 (xx) |
| IL (1) | IL183598A0 (xx) |
| MX (1) | MX2007007024A (xx) |
| NO (1) | NO20073547L (xx) |
| WO (1) | WO2006065217A1 (xx) |
| ZA (1) | ZA200705106B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2974365B1 (fr) * | 2011-04-20 | 2017-08-25 | Centre Nat De La Rech Scient (C N R S) | 1,2,3-triazoles 1,4-disubstituees, leurs procedes de preparation et leurs utilisations diagnostiques et therapeutiques |
| WO2016154434A1 (en) * | 2015-03-25 | 2016-09-29 | The Regents Of The University Of California | Selective alpha-7 nicotinic receptor agonists and methods for making and using them |
| WO2023213739A1 (en) * | 2022-05-05 | 2023-11-09 | Philip Morris Products S.A. | Nicotinic acetylcholine receptor ligands |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| US5041450A (en) * | 1988-06-29 | 1991-08-20 | Research Corporation Technologies, Inc. | Treatment of ocular inflammation |
| US5135935A (en) * | 1991-05-17 | 1992-08-04 | Merck & Co., Inc. | Squalene synthetase inhibitors |
| DE60311853T2 (de) * | 2002-09-30 | 2007-06-21 | Neurosearch A/S | Neue 1,4-diazabicycloalkanderivate, deren herstellung und verwendung |
| SE0303076D0 (sv) * | 2003-11-19 | 2003-11-19 | Astrazeneca Ab | 5-substituted imidazoles |
| SE0303075D0 (sv) * | 2003-11-19 | 2003-11-19 | Astrazeneca Ab | 4-substituted imidazoles |
-
2005
- 2005-12-14 AU AU2005317235A patent/AU2005317235A1/en not_active Abandoned
- 2005-12-14 US US11/721,483 patent/US20080103170A1/en not_active Abandoned
- 2005-12-14 EP EP05816721A patent/EP1831212A4/en not_active Withdrawn
- 2005-12-14 MX MX2007007024A patent/MX2007007024A/es not_active Application Discontinuation
- 2005-12-14 CA CA002592321A patent/CA2592321A1/en not_active Abandoned
- 2005-12-14 KR KR1020077013576A patent/KR20070086273A/ko not_active Application Discontinuation
- 2005-12-14 BR BRPI0518547-5A patent/BRPI0518547A2/pt not_active IP Right Cessation
- 2005-12-14 WO PCT/SE2005/001919 patent/WO2006065217A1/en active Application Filing
- 2005-12-14 JP JP2007546611A patent/JP2008524212A/ja not_active Abandoned
- 2005-12-14 CN CNA200580048141XA patent/CN101119994A/zh active Pending
-
2007
- 2007-05-31 IL IL183598A patent/IL183598A0/en unknown
- 2007-06-15 ZA ZA200705106A patent/ZA200705106B/xx unknown
- 2007-07-09 NO NO20073547A patent/NO20073547L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006065217A1 (en) | 2006-06-22 |
| NO20073547L (no) | 2007-08-01 |
| MX2007007024A (es) | 2007-07-04 |
| EP1831212A4 (en) | 2010-01-13 |
| IL183598A0 (en) | 2007-09-20 |
| CN101119994A (zh) | 2008-02-06 |
| BRPI0518547A2 (pt) | 2008-11-25 |
| JP2008524212A (ja) | 2008-07-10 |
| AU2005317235A1 (en) | 2006-06-22 |
| EP1831212A1 (en) | 2007-09-12 |
| US20080103170A1 (en) | 2008-05-01 |
| KR20070086273A (ko) | 2007-08-27 |
| CA2592321A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL183603A0 (en) | Nicotinic acetylcholine receptor ligands | |
| HUS000495I2 (hu) | Necitumumab | |
| EP1741703A4 (en) | PYRIDONE DERIVATIVE | |
| ZA200703912B (en) | 3-arylamino pyridine derivatives | |
| IL180430A0 (en) | Pyridine derivatives | |
| AP2006003786A0 (en) | Tetrahydronaphthyridine derivatives useful as histamine H3 receptor ligands | |
| IL181575A0 (en) | Anti-ox40l antibodies | |
| IL228032A0 (en) | Antibodies | |
| IL195019A0 (en) | Nicotinic acetylcholine receptor ligands 101 | |
| IL175993A0 (en) | Nicotinic acetylcholine receptor ligands | |
| GB0420466D0 (en) | Anti-glucan antibodies | |
| EP1891036A4 (en) | SELECTIVE LIGANDS OF THE ALPHA 7 NICOTINIC RECEPTOR | |
| IL173265A0 (en) | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazcpine receptor ligands | |
| ZA200701952B (en) | Anti-OX40L antibodies | |
| ZA200705106B (en) | Nicotinic acetycholine receptor ligands | |
| IL176073A0 (en) | Nicotinic acetylcholine receptor ligands | |
| GB0505420D0 (en) | Stable ligand selection method | |
| IL176071A0 (en) | Nicotinic acetylcholine receptor ligands | |
| GB0414998D0 (en) | Monodonor ligands | |
| GB0408808D0 (en) | Synchroniser | |
| ZA200705042B (en) | Nicotinic acetylcholine receptor ligands | |
| GB0414798D0 (en) | Receptor | |
| ZA200809396B (en) | Nicotinic acetylcholine receptor ligands 101 | |
| AU2004905087A0 (en) | Receptor specific ligands | |
| GB0403014D0 (en) | Ligands |